The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid profit-booking following Monday’s sharp rally — the strongest single-day gain in the past four years for the benchmark indices.
BofA initiates coverage on Polycab, KEI with buy ratings; sees up to 22% upside
BofA expects India’s wires and cables industry to grow at a 14% compound annual rate between FY26 and FY29, supported by spending on infrastructure, renewable